TransMedics Reports Third Quarter 2019 Financial Results
TransMedics Group, Inc. (TMDX)
Last transmedics group, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
ANDOVER, Mass., Nov. 06, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today reported financial results for the quarter ended September 28, 2019. Recent Highlights Net revenue of $7.2 million in the third quarter of 2019, representing 78% growth compared to the third quarter of 2018Gross margin of 59% in the third quarter of 2019Completed enrollment in 300 patient PROTECT OCS Liver pivotal trial “We are pleased with our third quarter results which showed revenue growth in all three of our OCS programs and demonstrates the strength of our multi-organ platform strategy,” said Waleed Hassanein, M.D., President and Chief Executive Officer of TransMedics. “We are influencing and driving a significant transformation in the global transplant field, and we look forward to continued U.S. commercial traction with the OCS Lu
Show less
Read more
Impact Snapshot
Event Time:
TMDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMDX alerts
High impacting TransMedics Group, Inc. news events
Weekly update
A roundup of the hottest topics
TMDX
News
- Shareholders that Lost Money on TransMedics Group, Inc. (TMDX) Should Contact Levi & Korsinsky About Securities Fraud Investigation - TMDXAccesswire
- TMDX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by TransMedics Group, Inc.Accesswire
- Down 52%, Is TransMedics Stock a Buy on the Dip? [Yahoo! Finance]Yahoo! Finance
- ATTENTION TransMedics Group, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your RightsAccesswire
- Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into TransMedics Group, Inc. (NASDAQ: TMDX)Business Wire
TMDX
Earnings
- 10/28/24 - Miss
TMDX
Sec Filings
- 11/13/24 - Form 4
- 11/7/24 - Form 4
- 11/5/24 - Form 4
- TMDX's page on the SEC website